Novel Drug Candidate Regenerates Pancreatic Cells Lost in Diabetes
March 9, 2015
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, funded by JDRF and the National Institutes of Health, and published online today in Nature Medicine.
Yaron Tomer, MD, FACP, is Director of the Metabolism Institute, Professor of Medicine and Chief of the Hilda & J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease. Read More
After he enrolled in Mount Sinai's medically supervised Weight Management Program, Robert Branch lost 120-pounds and ran the New York City Marathon. View Now
One Gustave L. Levy Place
New York, NY 10029
Read The Hilda & J. Lester Gabrilove Division of Endocrinology, Diabetes, and Bone Disease Annual Report [PDF].